During the past decade, Cancer Care Northwest-North Spokane conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 20 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 15 clinical trials were completed. i.e. 1500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Care Northwest-North Spokane" #1 sponsor was "SWOG Cancer Research Network" with 9 trials, followed by "National Cancer Institute (NCI)" with 8 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "NSABP Foundation Inc" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care Northwest-North Spokane" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Chiron Corporation" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Care Northwest-North Spokane" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Breast Cancer" (5 trials), "Colorectal Cancer" (3 trials) and "Breast Ductal Carcinoma In Situ" (2 trials). Many other conditions were trialed in "Cancer Care Northwest-North Spokane" in a lesser frequency.

Most popular intervention types in "Cancer Care Northwest-North Spokane" are "Drug" (27 trials), "Other" (22 trials), "Biological" (13 trials), "Radiation" (6 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (16 trials), "Docetaxel" (6 trials), "Quality-of-Life Assessment" (6 trials), "Carboplatin" (3 trials) and "Clinical Observation" (3 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Care Northwest-North Spokane" are 23 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Care Northwest-North Spokane". undefined are not yet recruiting, 2 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Cancer Care Northwest-North Spokane, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Care Northwest-North Spokane, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".